FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2112451353> ?p ?o ?g. }

• W2112451353 endingPage "838" @default.
• W2112451353 startingPage "830" @default.
• W2112451353 abstract "The rate of loss of tumour control (dP/dt) with extension of treatment time is analysed to assess the relative contributions of radiobiological parameters (radiosensitivity, clonogen doubling time, clonogen numbers and fractionation schedule) on such loss. Linear quadratic modelling and Poisson statistics are used to study individual tumour responses. A heterogeneous tumour population is constructed by the use of random sampling techniques to allow for variations in intrinsic radiosensitivity and clonogen doubling times. Average tumour control probability is calculated for this population for two different fractionation schedules (60 Gy in 30 fractions and 50 Gy in 15 fractions), each given over 15-60 days. The magnitude of dP/dt will depend upon the tumour cure probability (P): the loss of control will be most significant for tumours which have a cure of 37% when the Poisson survival model is used. The analysis suggests that compensation for short unscheduled treatment gaps (e.g. by increasing the total dose or rescheduling with use of weekend treatment sessions) may only be required for difficult tumours (i.e. radioresistant and/or with short clonogen doubling times). Where pre-treatment clonogen numbers are relatively low as in small volume tumours or after surgical debulking, the model predicts that correction for short treatment gaps is probably not required if the average effective clonogen doubling times are longer than 5 days. Different dose-time-fractionation schedules, even though producing similar overall cure rates in clinical practice, may actually be achieving cures in different subpopulations within a population of tumours, since the value of dP/dt in each individual tumour will depend upon the set of radiobiological parameters given above. For a hypothetical randomly selected heterogeneous tumour population the predicted rates of loss of tumour control produced by an extension in treatment time are 0.9 and 1.1% per day, respectively, for the above fractionation schedules. These values are close to those reported in the clinical literature for the first 2 weeks of treatment prolongation (1-2% per day for squamous cell carcinomas). The Poisson method, when combined with random sampling techniques, consequently provides realistic data. Modelling of this clinical problem provides an insight into how tumour sub-populations, each characterized by its own set of radiobiological parameters, can influence the overall rate of loss of tumour control in a heterogeneous population. Random sampling techniques should be considered as necessary precursors for the assessment of the choices of dose-fractionation in future clinical trials particularly when more precise data regarding the radiobiological parameters and their statistical variations become available." @default.
• W2112451353 created "2016-06-24" @default.
• W2112451353 creator A5052148476 @default.
• W2112451353 creator A5063288167 @default.
• W2112451353 date "1996-09-01" @default.
• W2112451353 modified "2023-09-26" @default.
• W2112451353 title "The reduction of tumour control with increasing overall time: mathematical considerations" @default.
• W2112451353 cites W1965359016 @default.
• W2112451353 cites W1971747664 @default.
• W2112451353 cites W1974881970 @default.
• W2112451353 cites W1980126077 @default.
• W2112451353 cites W1993337480 @default.
• W2112451353 cites W1994245313 @default.
• W2112451353 cites W2002956976 @default.
• W2112451353 cites W2006723414 @default.
• W2112451353 cites W2009216609 @default.
• W2112451353 cites W2012624981 @default.
• W2112451353 cites W2018729571 @default.
• W2112451353 cites W2020378886 @default.
• W2112451353 cites W2023879046 @default.
• W2112451353 cites W2026055653 @default.
• W2112451353 cites W2031982430 @default.
• W2112451353 cites W2034432128 @default.
• W2112451353 cites W2043823599 @default.
• W2112451353 cites W2045252618 @default.
• W2112451353 cites W2050754631 @default.
• W2112451353 cites W2056044238 @default.
• W2112451353 cites W2060769059 @default.
• W2112451353 cites W2073625280 @default.
• W2112451353 cites W2076319706 @default.
• W2112451353 cites W2078592572 @default.
• W2112451353 cites W2078855847 @default.
• W2112451353 cites W2090896110 @default.
• W2112451353 cites W2105150213 @default.
• W2112451353 cites W2106816194 @default.
• W2112451353 cites W2108162863 @default.
• W2112451353 cites W2111685034 @default.
• W2112451353 cites W2123311454 @default.
• W2112451353 cites W2130157110 @default.
• W2112451353 cites W2138477625 @default.
• W2112451353 cites W2147572114 @default.
• W2112451353 cites W2154488733 @default.
• W2112451353 cites W4236549981 @default.
• W2112451353 doi "https://doi.org/10.1259/0007-1285-69-825-830" @default.
• W2112451353 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/8983587" @default.
• W2112451353 hasPublicationYear "1996" @default.
• W2112451353 type Work @default.
• W2112451353 sameAs 2112451353 @default.
• W2112451353 citedByCount "18" @default.
• W2112451353 countsByYear W21124513532014 @default.
• W2112451353 countsByYear W21124513532015 @default.
• W2112451353 countsByYear W21124513532016 @default.
• W2112451353 countsByYear W21124513532020 @default.
• W2112451353 countsByYear W21124513532021 @default.
• W2112451353 crossrefType "journal-article" @default.
• W2112451353 hasAuthorship W2112451353A5052148476 @default.
• W2112451353 hasAuthorship W2112451353A5063288167 @default.
• W2112451353 hasConcept C100906024 @default.
• W2112451353 hasConcept C105795698 @default.
• W2112451353 hasConcept C126894567 @default.
• W2112451353 hasConcept C185592680 @default.
• W2112451353 hasConcept C202751555 @default.
• W2112451353 hasConcept C2908647359 @default.
• W2112451353 hasConcept C2989005 @default.
• W2112451353 hasConcept C33923547 @default.
• W2112451353 hasConcept C48900799 @default.
• W2112451353 hasConcept C55493867 @default.
• W2112451353 hasConcept C71924100 @default.
• W2112451353 hasConcept C99454951 @default.
• W2112451353 hasConceptScore W2112451353C100906024 @default.
• W2112451353 hasConceptScore W2112451353C105795698 @default.
• W2112451353 hasConceptScore W2112451353C126894567 @default.
• W2112451353 hasConceptScore W2112451353C185592680 @default.
• W2112451353 hasConceptScore W2112451353C202751555 @default.
• W2112451353 hasConceptScore W2112451353C2908647359 @default.
• W2112451353 hasConceptScore W2112451353C2989005 @default.
• W2112451353 hasConceptScore W2112451353C33923547 @default.
• W2112451353 hasConceptScore W2112451353C48900799 @default.
• W2112451353 hasConceptScore W2112451353C55493867 @default.
• W2112451353 hasConceptScore W2112451353C71924100 @default.
• W2112451353 hasConceptScore W2112451353C99454951 @default.
• W2112451353 hasIssue "825" @default.
• W2112451353 hasLocation W21124513531 @default.
• W2112451353 hasLocation W21124513532 @default.
• W2112451353 hasOpenAccess W2112451353 @default.
• W2112451353 hasPrimaryLocation W21124513531 @default.
• W2112451353 hasRelatedWork W1500184395 @default.
• W2112451353 hasRelatedWork W2033525850 @default.
• W2112451353 hasRelatedWork W2058213488 @default.
• W2112451353 hasRelatedWork W2092568834 @default.
• W2112451353 hasRelatedWork W2111056386 @default.
• W2112451353 hasRelatedWork W2114668360 @default.
• W2112451353 hasRelatedWork W2148656812 @default.
• W2112451353 hasRelatedWork W2325043183 @default.
• W2112451353 hasRelatedWork W2392413698 @default.
• W2112451353 hasRelatedWork W2118673085 @default.
• W2112451353 hasVolume "69" @default.
• W2112451353 isParatext "false" @default.

• next